What is he best known for?
The fields of study he is best known for:
- Cancer
- Pathology
- Internal medicine
His primary scientific interests are in Pathology, Immunohistochemistry, Anatomy, Carcinoma and Myoepithelial cell.
Many of his studies involve connections with topics such as Adenocarcinoma and Pathology.
His study in Immunohistochemistry is interdisciplinary in nature, drawing from both Fluorescence in situ hybridization, Cancer research, Cancer and ETV6.
His biological study spans a wide range of topics, including Angioma, Extracellular matrix, Cytokeratin and Psammoma body.
The various areas that he examines in his Carcinoma study include Thyroid, Stroma, Renal cell carcinoma and Lymph node.
Michal Michal works mostly in the field of Myoepithelial cell, limiting it down to topics relating to Metaplasia and, in certain cases, Apocrine.
His most cited work include:
- Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. (567 citations)
- Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. (429 citations)
- Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. (171 citations)
What are the main themes of his work throughout his whole career to date?
Michal Michal mainly focuses on Pathology, Immunohistochemistry, Carcinoma, Anatomy and Vimentin.
As part of his studies on Pathology, he often connects relevant areas like Kidney.
His research integrates issues of Differential diagnosis and Fluorescence in situ hybridization in his study of Immunohistochemistry.
Carcinoma is closely attributed to Adenocarcinoma in his study.
His Soft tissue research extends to Anatomy, which is thematically connected.
His study of Papillary renal cell carcinomas is a part of Renal cell carcinoma.
He most often published in these fields:
- Pathology (87.27%)
- Immunohistochemistry (22.03%)
- Carcinoma (14.45%)
What were the highlights of his more recent work (between 2016-2021)?
- Pathology (87.27%)
- Immunohistochemistry (22.03%)
- Carcinoma (14.45%)
In recent papers he was focusing on the following fields of study:
Michal Michal mostly deals with Pathology, Immunohistochemistry, Carcinoma, Adenocarcinoma and Cancer research.
His Pathology research integrates issues from Fluorescence in situ hybridization and Cell.
Michal Michal interconnects Fusion gene, Kidney and Clear cell renal cell carcinoma in the investigation of issues within Immunohistochemistry.
His Adenocarcinoma research includes themes of KRAS and Salivary gland.
His Cancer research study integrates concerns from other disciplines, such as Mutation and Gene.
His studies in Vimentin integrate themes in fields like Papillary renal cell carcinomas and CD117.
Between 2016 and 2021, his most popular works were:
- Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases. (87 citations)
- Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases (47 citations)
- Recurrent somatic PDGFRB mutations in sporadic infantile/solitary adult myofibromas but not in angioleiomyomas and myopericytomas (39 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Pathology
His main research concerns Pathology, Immunohistochemistry, Fusion gene, Carcinoma and Fluorescence in situ hybridization.
His Pathology study frequently draws parallels with other fields, such as CD117.
Michal Michal has included themes like Lesion, In situ hybridization, Tumor-infiltrating lymphocytes, Receptor and Adenoid cystic carcinoma in his Immunohistochemistry study.
His Fusion gene research is multidisciplinary, relying on both Stromal cell, ETV6, Massive parallel sequencing and Neurofibromatosis.
His Carcinoma study combines topics in areas such as Cancer research, Gene rearrangement, Infiltrative Growth Pattern, Microdissection and Basal cell carcinoma.
His Fluorescence in situ hybridization study combines topics from a wide range of disciplines, such as Pleomorphic lipoma, Superficial acral fibromyxoma, Soft tissue, Rb Protein and Retinoblastoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
